PLEASE PLAN TO JOIN ACTIVISTS, CITIZENS, REPRESENTATIVES AND OTHERS AT THE 2020 CANNABIS RALLY AT THE ROTUNDA, THIS WEDESDAY, MARCH 11TH, FROM 12:30PM UNTIL 2:00PM.
LOCATED AT 700 CAPITAL AVENUE, FRANKFORT, KY 40601.
Kentucky House Judiciary Committee advances medical cannabis bill!
Seriously ill Kentuckians have been waiting long enough — urge your state legislators to support HB 136!
Today, Kentucky’s House Judiciary Committee voted 17-1 to pass HB 136, a bill that would legalize cannabis for medical use. Next the bill will proceed to the full House, where it is expected to receive a vote soon.
Please write your legislators today and urge them to pass this compassionate legislation!
Fifty-one of Kentucky’s 100 state representatives are cosponsors of HB 136, and Gov. Andy Beshear has indicated that he strongly supports medical cannabis.
However, some Senate leaders remain opposed, so the challenge for advocates will be getting a bill through both chambers of the legislature and to the governor’s desk.
It’s critical that legislators hear from their constituents who support medical cannabis. After you write your legislators, please share this message with your friends and family.
PLEASE BE ADVISED THAT HB136 IS A NON SMOKABLE NON GROWABLE BILL! IT IS STRICTLY FOR MEDICAL CONSUMPTION ONLY!
“to prohibit smoking of medicinal marijuana;”
“to establish limits on the THC content of medicinal marijuana that can be produced or sold in the state”
“to exempt certain records and information from the disclosure under the Kentucky Open Records Act;”
“to permit an employer to restrict the possession and use of medicinal marijuana by an employee;”
“to allow for possession, growth, use, processing, purchasing, transfer, and consumption of cannabis;”
“to establish provisions for personal cultivation;”
“to establish provisions for palliative or therapeutic use of cannabis by persons under the age of 21;”
The people of Kentucky, all groups, all BILLS for Cannabis whether it be “Medical” or “Adult Use”, Republican, Democrat, Libertarian or Independent, are requested to join us in Frankfort Kentucky on March 11, 2020 to show our support for the effort in our State!
LOCATED AT CAPITOL ROTUNDA
700 CAPITOL AVE
FRANKFORT, KY 40601
AN ACT relating to medicinal marijuana and making an appropriation therefor.
AN ACT relating to the regulation of cannabis and making an appropriation therefor.
AN ACT relating to hemp and declaring an emergency.
AN ACT relating to marijuana possession.
AN ACT relating to employment-related drug screens.
RELATED GROUPS/PAGES ON FACEBOOK!
MY RIGHT TO DECIDE
KENTUCKY 411 UNCENSORED
KENTUCKY MARIJUANA PARTY
FREE THE WEED KENTUCKY
(The AEGIS Alliance) – ST. PETERSBURG, FLORIDA – A Florida man was arrested on Saturday in St. Petersburg by police because he was handing out marijuana for free to people who passed by “because it was Christmas,” WFLA reported.
A digital weighing scale was also discovered on Spurrier’s person, along with a prescription bottle that had his name on it, and a glass pipe. Police also discovered a sword that was hidden inside Mr Spurrier’s walking cane.
Mr Spurrier is being charged with possession of marijuana with the intent to distribute and possession of drug paraphernalia. Richard Ellis Spurrier was released from police custody on Sunday.
There are some Floridians who seem more than happy to share the green substance when they are in possession of the recreational marijuana.
Mr Arthur Carracino had flagged down officers before telling them that fateful statement and showed off his marijuana plant to them, and admitted he grew the plant, Mr Carracino was then arrested by police.
Medical marijuana in Florida has been legal since 2016, and there is a resolution being proposed to decriminalize it in the amount of 20 gram or less. Florida legislature is expected to vote on the recreational marijuana resolution in 2020.
However, there are those opposed to the proposal of recreational marijuana in Florida. Floridians Against Marijuana, or FARM made an announcement in November that it intends to prevent marijuana legalization in Florida known as “the Sunshine State.”
“Our coalition has come together to defeat this dangerous ballot initiative, which will drive an increase in health care prices, increase costs on businesses and kill jobs and increase the burden on taxpayers that will pay for the costs associated with recreational marijuana,” Brian Swensen said in a news release, the campaign manager for FARM, Tallahassee.com reported.
Unfortunately Florida Senator Marco Rubio also opposed marijuana legalization during his 2016 campaign when he told rally goers he believed “pot is an insidious as alcohol.”
“No one can tell me that alcohol’s had a positive impact on society. “It destroys marriages and lives. It kills people… and now you want to add another intoxicant and make it legal?” Rubio stated.
“There’s no positive impact to using marijuana,” Rubio mentioned. “Now, if there’s a medicinal use, if you can go to the FDA and prove that it helps with medicine, that’s fine. Then turn it into medicine.”
Video courtesy of WFLA that initially reported on this story:
Monday, Nov. 11, 2019 | Author: ProCon.org
Kentucky, where both recreational and medical marijuana are illegal, grows more illicit marijuana plants per 100,000 people than any other state, according to DEA data analyzed by American Addiction Centers. In 2018, the US Drug Enforcement Administration (DEA) eradicated 418,076 cannabis plants in Kentucky, about 9,356 plants per 100,000 people.
California, which legalized medical marijuana in 1996 and recreational marijuana in 2016, came in second place with 4,572 illegal cannabis plants per 100,000 people. The DEA confiscated over 1.8 million marijuana plants in the state last year.
Massachusetts and Wyoming tied for last place with zero cultivated plants seized by the DEA in 2018. Wyoming has not legalized marijuana, but Massachusetts legalized medical marijuana in 2012 and adult-use (also called recreational) cannabis in 2016.
Across the United States, the DEA seized 2.82 million cannabis plants in 2018, down from 3.38 million plants in 2017.
Kentucky also earned first place in the number of destroyed illegal grow sites in the country. 15 grow sites per 100,000 people were destroyed in Kentucky, more than double the next-highest state, West Virginia (7.4 per 100,000 people). West Virginia legalized medical marijuana in 2017 but has not legalized recreational use.
Delaware, DC, Maine, Massachusetts, Minnesota, North Dakota, Pennsylvania, Rhode Island, South Dakota, Vermont, and Wyoming all had zero grow sites destroyed per 100,000 people. Except Wyoming, each of those states and DC have legalized medical marijuana, and 3 states and DC have legalized recreational use: Maine, Massachusetts, and Vermont.
Despite not having any plants seized, Wyoming bulk-processed the most marijuana at 1,095 pounds per 100,000 people, 46.8% more than the next highest state, Arizona, which had 746 pounds per 100,000 people. Arizona legalized medical marijuana in 2010. American Addiction Centers theorized that the marijuana being bulk-processed in Wyoming might come from nearby states that have legalized marijuana, such as Colorado.
Delaware, DC, Illinois, Maine, Minnesota, North Dakota, Rhode Island, South Dakota, Tennessee, and Vermont bulk-process the least amount of marijuana (0 pounds per 100,000 people). Among those states, only South Dakota and Tennessee have not legalized marijuana for medical use. Three of those states and DC also have recreational marijuana: Illinois, Maine, and Vermont.
The DEA’s Domestic Cannabis Eradication/Suppression Program seized $52,308,982 in assets related to illicit cannabis plants last year.
33 states and DC have legal medical marijuana, and 11 states and DC have legal recreational marijuana.
Read what the 2020 candidates think about recreational marijuana legalization on our 2020 election site.
Our son, Edwin Rubis, is serving a federal sentence of 40 years for a non-violent marijuana offense. [www.marijuanaliferproject.org/federal-prisoner-edwin-rubis-is-serving-life-for-marijuana/
At age 29, our son, while battling drug addiction, associated himself with drug couriers, and was charged with conspiracy to distribute marijuana. After his arrest, his court-appointed attorney advised him, along with us, that he needed to provide information on others in the drug trade. Edwin could not provide such information. Therefore, he was quickly deemed “uncooperative”, and the judge gave him a harsh sentence – 40 years.
During the course of time, we have adamantly petitioned, and at times cried, for his early release, at every level of the court system. Sadly to say, we continue to struggle, missing him, with no positive resolution to obtain his freedom. Edwin’s children need him. We need him. Our son is not a terrorist, a rapist, a gang member, nor a violent individual to continually be kept in prison for decades for distributing marijuana. While imprisoned, Edwin has taken diligent steps to better himself. He has achieved numerous rehabilitation programs from the psychology and religious departments. He has graduated from college with a degree in Religious Education; and he is currently pursuing a Master’s degree in Counseling and Therapist Certification. In addition, he serves as a mentor to others, under the supervision of the head chaplain. He is also working as a G.E.D. and E.S.L. tutor in the education department, at his present institution of confinement, helping others further their education. In addition, Edwin also finished a 2 year dental apprenticeship from The Department of Labor, and worked as a dental assistant for the last 7 years in the medical department.
We love our son, [uncle, father, and brother]. We wish for him to receive another chance at life. But our dream for him to be reunited with us, can not be accomplished without your full support.
Edwin is a changed man. He has been fully rehabilitated and deserves a second chance at life.
Sincerely, Maria Roque – and – Family.
There’s a professional society for seemingly every kind of medical specialist, even cannabis clinicians.
Or medical marijuana physicians. Or pot doctors, in street parlance.
And just as there’s a choice of what to call physicians who use the plant to treat everything from pain to multiple sclerosis, there’s a choice of three different medical associations to represent them. Their emergence over the past 15 years coincides with the legalization of medical marijuana in 29 states and Washington, DC, and recreational marijuana in eight states and DC.
The three associations amount to friendly rivals that strive for professional respectability, which hasn’t always attended their field. David Bearman, MD, a board member of the American Academy of Cannabinoid Medicine (AACM), castigates medical marijuana dispensaries that have hired bikini-clad young women to lure passersby inside for a quick visit with an on-site clinician.
“We wanted to marginalize those people,” Dr Bearman told Medscape Medical News about the formation of his group.
The AACM, the Society of Cannabis Clinicians (SCC), and the American Medical Marijuana Physicians Association (AMMPA) all want to educate the public and the medical profession alike about marijuana and its therapeutic chemicals and see more research in this field. Despite strong headwinds from the federal government, one being an unsympathetic attorney general, they have high hopes for their work, which they say could become a bonafide medical specialty.
They have their own electronic medical marijuana record, for crying out loud.
The SCC is the oldest of the three marijuana physician societies, formed in 2004 by the California Research Medical Group. That organization, in turn, was created by the late Tod Mikuriya, MD, who helped write the seminal 1996 ballot resolution in California that legalized medical marijuana and caught fire in other states.
Of the group’s roughly 350 members, about half are physicians in specialties as diverse as geriatrics, pediatrics, emergency medicine, and psychiatry, SCC President Jeffrey Hergenrather, MD, told Medscape Medical News. Membership, which costs $150 a year, is open to any clinician, be it naturopath or nurse practitioner, who is authorized by his or her state to “recommend” medical marijuana (prescribing is reserved for legal drugs). Membership has spread from the West Coast across the country and abroad.
The group offers, among other things, courses on medical marijuana good for continuing medical education (CME) credits, online quarterly meetings, and a collection of case reports on the group’s website (“Neuroblastoma, a childhood cancer, was treated with cannabis after failure of conventional therapy. Cancer disappeared after 4 years of regular cannabis use.”).
Physicians like Dr Hergenrather would argue that human beings are made for medical marijuana, given the body’s recently discovered endocannabinoid system. Endocannabinoids are retrograde neurotransmitters that attach to cannabinoid receptors in the nervous system and help regulate pain, appetite, memory, immune response, and other bodily functions. Marijuana plants contain more than 100 biological cousins called phytocannabinoids — chief among them tetrahydrocannabinol (THC) and cannabidiol (CBD) — that work like natural endocannabinoids to bring the body into balance, said Dr Hergenrather, a self-styled “cannabis consultant” in Sebastopol, California. Marijuana also contains molecules called terpenes that can reduce anxiety or control seizures, he said, but phytocannabinoids inspire the most medical interest.
The Marijuana Justice Act of 2017, introduced by New Jersey Democratic Senator Cory Booker, is exactly the criminal justice and health legislation this country so needs. Much like Bernie Sander’s bill in the last Congress, this act would not reschedule, but actually deschedule cannabis out of the Controlled Substance Act altogether. As its name implies, the passage of this act, S. 1689, would provide true marijuana justice in the USA. Tragically, it has received zero cosponsors in the Senate. An analysis by Skopos Lab artificial intelligence gives it only a 1% chance of being enacted.
The similar bill by Senator Bernie Sanders (D – Ver) in the last Congress likewise got no cosponsors, not even Cory Booker, and died. Similarly, neither Bernie Sanders nor any other senator has cosponsored the 2017 bill. A portion of GovTrack’s summary of S. 1689 follows:
The Marijuana Justice Act, introduced by Sen. Cory Booker (D-NJ), would end the federal prohibition on marijuana once and for all, by removing the drug from the DEA’s list of controlled substances entirely.
It would also apply retroactively, allowing for judicial review of anybody serving a prison sentence for drug possession. (Although virtually nobody in America goes to jail just for marijuana possession or use, the charge is often used to add time to a jail sentence primarily handed down for conviction of another drug-related crime such as selling or trafficking.)
Lastly, the bill would use federal expenditures to incentive states to legalize the drug “if those laws were shown to have a disproportionate effect on low-income individuals and/or people of color.” As Vox points out, that designation applies to almost every state. Therefore, this bill would effectively authorize federal expenditures to support nationwide legalization at the state level as well.
It was introduced as Senate bill number S. 1689. (Unfortunately, S. 420 was already taken.)
A version of the bill introduced into the House of Representative by Thomas Garrett (R-Vir) is doing better. With 15 House cosponsors, H.R. 1227: Ending Federal Marijuana Prohibition Act of 2017 is given a 9% chance of passage by Skopos Labs. The 15 cosponsors are cannabis freedom fighters. They are:
The Senate (and House) have seen other action on the marijuana front. Oregon Senator Ron Wyden introduced S. 780: Responsibly Addressing the Marijuana Policy Gap Act of 2017. This act would not deschedule cannabis but does provide legal protection in legal states. The bill has a counterpart in the House, Earl Blumenauer’s H.R. 1824, now with seven cosponsors.
If your Senators and Representatives are absent on these important bills, call them and urge they cosponsor.
Interest in cannabis liberation extends back to the 1960s for Don Fitch. Most of his career has been in high tech and pr … More!
Submitted by Marijuana News on Fri, 06/09/2017 – 08:45
The marijuana market in Canada is prepped for additional growth: several companies plan to go public in 2017 since the country’s regulations are more favorable, giving investors more options in this growing sector.
Companies are choosing to file their IPOs in Canada because of the more restrictive environment in the U.S., said Michael Berger, founder of Technical420, a Miami-based company that conducts research on cannabis stocks, and a former Raymond James energy analyst. The legal cannabis market expanded significantly during the past year and medical marijuana is now legal in countries such as Australia, Germany, Canada, Uruguay and Colombia.
By 2018, Canada’s legal recreational cannabis market should generate over $10 billion a year.
“One theme we recognized over the last year is an increasing number of companies listing on Canadian stock exchanges,” he said. “These companies are choosing to list in Canada due to better business policies.”
The number of registered patients is growing at a rapid pace in Canada as licensed producers continue to find innovative ways to create value for its shareholders. The number of patients is nearly 200,000 and growing 10% on a month over month basis, Berger said. The liquidity in the market is also beneficial for investors.
“In Canada, companies can use bank accounts, claim taxes, and write off business expenses legally unlike the U.S. where cannabis companies cannot do any of that and are frequently switching banks on account of their account being closed due to the focus on the cannabis industry,” he said.
The Canadian marijuana market and legislation is outpacing the U.S. because Canada has legalized medicinal and recreational marijuana on the federal level, said Jason Spatafora, co-founder of Marijuanastocks.com and a Miami-based trader and investor known as @WolfofWeedST on Twitter.
“Canada has allowed licensed producers of cannabis to take their companies public in a meaningful way compared to the U.S. since there are still American companies which do not touch the plant directly,” he said.
A medical cannabis producer, The Green Organic Dutchman Holdings, is planning to go public in the second half of 2017, said Berger. The company cultivates medical marijuana under Health Canada from a 100-acre farm in Ancaster, Ontario and has already completed two oversubscribed financing rounds with over 2,500 investors, “which is a testament to the company’s leadership and success,” he said.
One factor investors need to consider is the track record of the management team and The Green Organic Dutchman has “one of the best in the industry,” Berger said. “The management team has a proven track record and they were the team that brought together OrganiGram (OGRMF) and Emblem Corp. (EMMBF), two successful Canadian licensed medical cannabis producers. Although the team’s role with those companies was different, they learned invaluable lessons which have also been implemented in this company.”
Compared to its competitors, the company has differentiated itself by growing organic cannabis and is levered to a market that is experiencing a 10% on a month-over-month basis on sales.
“The Organic Dutchman is part of a rapidly growing market, generates a strong balance sheet and consists of several strategic partners,” he said.
High Street Capital Partners, a New York-based real estate company that owns and operates cannabis cultivation facilities and dispensaries in 14 states across the U.S., could go public by the summer.
Although High Street is levered to the U.S. market, the company plans to list in Canada due to better regulatory environment. The company is an attractive opportunity since it has over 60% of the market share in Maine, 11 dispensaries in Illinois, one of the largest dispensaries in the Boston area and other attractive and profitable locations, said Berger.
Based in Ontario, CannTrust, a federally regulated licensed medical cannabis producer, is also planning to go public on the TSX this year. The company is an “attractive” opportunity, because it brings more than 40 years of pharmacy and healthcare experience to the cannabis industry. The company offers various proprietary products, operates out of a 40,000-square foot state-of-the-art hydroponic facility and its lab conducts testing and research on their products.
The risk of investing in IPOs for retail traders can be high, especially if they are not familiar with the industry since it is a nascent sector.
“For traders like myself IPOs are only interesting to me if they’re in an emerging market or if as a private company they have solved a problem or created a revenue generating efficiency,” said Spatafora. “IPOs do help fund innovation occasionally on a global sense, but they also pull liquidity from sectors and break hearts such as Snapchat.”
The most recent Canadian company to go public was medical producer Emblem Corp. (EMMBF), which went public on the TSX Venture Exchange in December 2016.
“This offering was nothing short of success,” said Berger. “Retail accredited investors purchased shares at $0.75 and $1.15 before the IPO. Once the shares commenced trading, Emblem was trading above the $3 level.”
Although the cannabis market is burgeoning, some newcomers could wind up not being profitable for several years. Choosing the winners is not always an exact science. Investors should be wary and conduct due diligence since popular stocks are not always profitable.
“Cannabis is an emerging market and as an investment it is a once in three generation opportunity that is barely through its first inning,” Spatafora said. “Just like dot com investors needed to pick their spots to invest in, people should not make just any marijuana investment.”
Investing in an early stage company is often riskier, said Berger.
“While the cannabis industry is the fastest growing industry in the world, leaning to an influx in the number of cannabis companies going public, we have seen several highly anticipated IPOs not live up to expectations and burn through its working capital before being able to deliver on its promises,” he said. “Investors need to look into the company’s balance sheet and determine if it has enough capital to execute on its plan and to make sure its deploying capital to the right places and not on management’s salaries.”
The word “marijuana” plays a controversial role in cannabis culture. Many well-known organizations such as Oakland’s Harborside Heath Center have publicly denounced “the M word” in favor of our favorite plant’s Latinate name, cannabis. Even Salon Magazine, a major press outlet outside of the cannabis industry, published an article titled “Is the word ‘Marijuana’ racist?” last year.
As mainstream culture becomes a little more herb-friendly, the terminology used by the industry is coming to center stage. But, why exactly does the term “marijuana” cause so much debate? Even worse, why has the word gained publicity as a racist term?
To save you from reading those lengthy history books or some boring academic articles, we’ve created this brief timeline to give you the low-down on “marijuana”’s rise to popularity in the United States. Here’s what you need to know:
Prior to 1910, “marijuana” didn’t exist as a word in American culture. Rather, “cannabis” was used, most often in reference to medicines and remedies for common household ailments. In the early 1900s, what have now become pharmaceutical giants—Bristol-Meyer’s Squib and Eli Lilly—used to include cannabis and cannabis extracts in their medicines.
During this time, Americans (particularly elite Americans) were going through a hashish trend. Glamorized by literary celebrities such as Alexander Dumas, experimenting with cannabis products became a fad among those wealthy enough to afford imported goods.
Between the years of 1910 and 1920, over 890,000 Mexicans legally immigrated into the United States seeking refuge from the wreckage of civil war. Though cannabis had been a part of U.S. history since the country’s beginnings, the idea of smoking the plant recreationally was not as common as other forms of consumption. The idea of smoking cannabis entered mainstream American consciousness after the arrival of immigrants who brought the smoking habit with them.
The first bill criminalizing the cultivation of “locoweed” was passed in California. The bill was a major push from the Board of Pharmacy as a way to regulate opiates and psychoactive pharmaceuticals, and seemingly did not stem from the “reefer madness” or racialized understanding of “marijuana” that paved the way to full-on prohibition in the 1930s.
The Great Depression had just hit the United States, and Americans were searching for someone to blame. Due to the influx of immigrants (particularly in the South) and the rise of suggestive jazz music, many white Americans began to treat cannabis (and, arguably, the Blacks and Mexican immigrants who consumed it) as a foreign substance used to corrupt the minds and bodies of low-class individuals.
In the time just before the federal criminalization of the plant, 29 states independently banned the herb that came to be known as “marijuana.”
It would not be an overstatement to say that Harry Anslinger was one of the primary individuals responsible for creating the stigma surrounding cannabis. Hired as the first director of the recently created Federal Bureau of Narcotics in 1930, Anslinger launched a vigilant campaign against cannabis that would hold steady for the three decades he remained in office.
A very outspoken man, Anslinger used the recent development of the movie theater to spread messages that racialized the plant for white audiences. In one documented incident, Anslinger testified before Congress, explaining:
“Marijuana is the most violence-causing drug in the history of mankind… Most marijuana smokers are Negroes, Hispanics, Filipinos and entertainers. Their satanic music, jazz and swing, result from marijuana usage.”
In another statement, Anslinger articulated: “Reefer makes darkies think they’re as good as white men…the primary reason to outlaw marijuana is its effect on the degenerate races.”
In retrospect, Anslinger’s efforts with the Bureau of Narcotics were the reason “marijuana” became a word known by Americans all over the country. When making public appearances and crafting propaganda films such as Reefer Madness, Anslinger specifically used the term “marijuana” when campaigning against the plant, adding to the development of the herb’s new “foreign” identity.
Cannabis was no longer the plant substance found in medicines and consumed unanimously by American’s all over the country.
The Marihuana Tax Act of 1937 was the culmination of Anslinger’s work and the first step to all-out prohibition. The bill federally criminalized the cannabis plant in every U.S. state. In order to discourage the production of cannabis use, the Tax Act of 1937 placed a one dollar tax on anyone who sold or cultivated the cannabis plant.
On top of the tax itself, the bill mandated that all individuals comply with certain enforcement provisions. Violation of the provisions would result in imprisonment and/or a fine of up to $2,000.
Though the word “marijuana” is the most common name for cannabis in the United States today, its history is deeply steeped in race, politics, and a complicated cultural revolution. Some argue that using the word ignores a history of oppression against Mexican immigrants and African Americans, while others insist that the term has now lost its prejudiced bite. Regardless of whether or not you decide to use the word yourself, it’s impossible to deny the magnitude and racial implications of its introduction to the American lexicon.